153 related articles for article (PubMed ID: 34590150)
41. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
42. Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancers.
Fan M; Arai M; Tawada A; Chiba T; Fukushima R; Uzawa K; Shiiba M; Kato N; Tanzawa H; Takiguchi Y
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738627
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression.
Liu DM; Yang H; Yuan ZN; Yang XG; Pei R; He HJ
Biochem Biophys Res Commun; 2020 Aug; 529(2):148-155. PubMed ID: 32703403
[TBL] [Abstract][Full Text] [Related]
44. The forkhead box transcription factor FoxP4 regulates thermogenic programs in adipocytes.
Perie L; Verma N; Mueller E
J Lipid Res; 2021; 62():100102. PubMed ID: 34384787
[TBL] [Abstract][Full Text] [Related]
45. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
Ma Y; Gong Z; Wang H; Liang Y; Huang X; Yu G
Pathol Res Pract; 2020 Nov; 216(11):153194. PubMed ID: 32916448
[TBL] [Abstract][Full Text] [Related]
46. LINC01605 promotes the proliferation of laryngeal squamous cell carcinoma through targeting miR-493-3p.
Wang XY; Wang L; Xu PC; Huang FJ; Jian X; Wei ZC; Chen YQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10379-10386. PubMed ID: 31841192
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
[TBL] [Abstract][Full Text] [Related]
48. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
[No Abstract] [Full Text] [Related]
49. OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
Tu XP; Li H; Chen LS; Luo XN; Lu ZM; Zhang SY; Chen SH
BMC Cancer; 2020 Aug; 20(1):794. PubMed ID: 32838760
[TBL] [Abstract][Full Text] [Related]
50. Participation of Long Noncoding RNA
Liu L; Zhao J; Guo H; Jia J; Shi L; Ma J; Zhang Z
Cancer Biother Radiopharm; 2024 Mar; ():. PubMed ID: 38512300
[No Abstract] [Full Text] [Related]
51. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
Zhang SY; Lu ZM; Lin YF; Chen LS; Luo XN; Song XH; Chen SH; Wu YL
Oncotarget; 2016 Mar; 7(10):11637-50. PubMed ID: 26826553
[TBL] [Abstract][Full Text] [Related]
52. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
[TBL] [Abstract][Full Text] [Related]
53. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.
Wu X; Xiao Y; Zhou Y; Zhou Z; Yan W
Cell Death Dis; 2019 Jun; 10(7):472. PubMed ID: 31209207
[TBL] [Abstract][Full Text] [Related]
54. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
55. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
56. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway.
Wu J; Chen Z; Zhang L; Cao J; Li X; Gong Z; Bo H; Zhang S; He D
J Cell Biochem; 2020 Jan; 121(1):867-875. PubMed ID: 31452270
[TBL] [Abstract][Full Text] [Related]
57. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
58. LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma.
Wang X; Zhao Y; Fei X; Lu Q; Li Y; Yuan Y; Lu C; Li C; Chen H
Int J Biol Sci; 2020; 16(13):2392-2404. PubMed ID: 32760207
[TBL] [Abstract][Full Text] [Related]
59. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
[TBL] [Abstract][Full Text] [Related]
60. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]